Jaguar E-PACE and Range Rover Velar help drive June sales growth

Jaguar Land Rover reported total retail sales of 52,049 vehicles in June 2018, up 0.9 percent year-onyear (YOY), primarily reflecting the introduction of the Range Rover Velar and Jaguar E-PACE.

The retail sales for June were up YOY in the overseas markets (16.7 percent), in North America (7.4 percent) and in the UK (0.9 percent). China was down 9.5 percent due to the reduction in import duties on passenger vehicles, starting July 1; it continued to result in deferred purchases as well as increased incentives in advance of the July 1 effective date. Europe was also down slightly (-3.8 percent).

Jaguar Land Rover Chief Commercial Officer Felix Brautigam said, “We have seen a positive month for Jaguar ahead of the start of customer deliveries of our Jaguar I-PACE, the car at the forefront of our electric vehicle revolution. Strong retails of the sporty and compact SUV Jaguar E-PACE in Europe, the UK and our overseas region are driving the sales performance for the brand, which is up over 6 percent for the month.”

“Land Rover sales declined slightly in June as China waited for the welcome reduction in import tariffs as of July. This was largely offset by increases in sales in the UK, USA and our overseas region. The award-winning Range Rover Velar continues to make its mark across all regions. Its combination of elegant design and refined capability successfully translates into growing global sales.”

Jaguar retail sales were up 6.4 percent in June to 16,328 thanks to the introduction of the E-PACE, partially offset by lower sales of F-PACE and other models. Land Rover retailed 35,721 vehicles in June, down 1.5 percent YOY as the introduction of Velar and increased the sales of the refreshed Range Rover Sport were offset by lower sales of Evoque, Discovery Sport and other models.

Jaguar Land Rover total retail sales for 1Q FY19 were 145,510, up 5.9 percent YOY and the retails for the first six months of 2018 calendar year were 318,219, up 0.4 percent compared to the same period a year ago.